Dovitinib-RIBOTAC

Overview

Dovitinib RIBOTAC is an RNA-targeting RIBOTAC degrader that can specifically bind to and degrade pre-miR-21 . Dovitinib RIBOTAC can inhibit the metastasis of breast cancer and has anti-tumor activity.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > RIBOTAC | Products > Signaling Pathways > Programmed Cell Death 4 (PDCD4) | Products > Signaling Pathways > PPAR

Product Information

• Catalog No.: HY-139682
• CAS No.: 2759351-68-1
• Molecular Formula: C51H56FN9O10S
• Molecular Weight: 1006.11
• Purity: 99.31%
• Storage: -20°C, protect from light, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
• Availability: In-stock

Source

Original product source